Intramuscular Lignocaine 2 and 10
Overview
Authors
Affiliations
Studies in 10 male volunteers has shown that intramuscular injection of 10% lignocaine produces similar blood lignocaine levels to those obtained with larger volumes of a less concentrated preparation. Since no local or general complications occurred it is suggested that the 10% solution is suitable for clinical use.
Plasma mexiletine concentrations following combined oral and intramuscular administration.
Bradbrook I, Feldschreiber P, Morrison P, Rogers H, Spector R Eur J Clin Pharmacol. 1981; 19(4):301-4.
PMID: 7286033 DOI: 10.1007/BF00562808.
Sutherland G, Bevan J, Bevan D Can Anaesth Soc J. 1983; 30(4):342-6.
PMID: 6871775 DOI: 10.1007/BF03007855.
Ryden L, Wasir H, Conradsson T, Olsson B Br Heart J. 1972; 34(10):1012-7.
PMID: 5086967 PMC: 458539. DOI: 10.1136/hrt.34.10.1012.